Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Annals of the Rheumatic Diseases|October 25, 2011
Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 StudyYukitomo Urata, Ryoko Uesato, Dai Tanaka, et al.Journal of Reconstructive Microsurgery|March 2, 2005
Combined rotational osteotomy and vascularized iliac bone graft for advanced osteonecrosis of the femoral headYoshihide Nakamura, Yasushi Kumazawa, Hiromasa Mitsui, et al.The Journal of Arthroplasty|January 26, 2010
Total hip arthroplasty using a cylindrical cementless stem in patients with a small physiqueYoshihide Nakamura, Hiromasa Mitsui, Akira Kikuchi, et al.Journal of Medical Case Reports|August 16, 2014
Identification of a novel COL2A1 mutation (c.1744G>A) in a Japanese family: a case reportMasaki Kishiya, Yoshihide Nakamura, Hirotaka Ohishi, et al.Modern Rheumatology|July 30, 2010
Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patientsYukitomo Urata, Ryoko Uesato, Dai Tanaka, et al.Pediatrics International : Official Journal of the Japan Pediatric Society|April 2, 2004
Spontaneous closure of ventricular septal defects followed up from <3 months of ageToshiharu Miyake, Tohru Shinohara, Yoshihide Nakamura, et al.Cardiology|October 6, 2012
An infant with heart failure due to ventricular dyssynchrony and refractory tachycardia caused by a right anterolateral accessory pathwayYukako Suzuki, Takeki Suzuki, Yasushi Imai, et al.Annals of Nuclear Medicine|May 12, 2021
Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition)Tadashi Watabe, Makoto Hosono, Seigo Kinuya, et al.Annals of Nuclear Medicine|July 6, 2022
Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)Naoyuki Ukon, Tatsuya Higashi, Makoto Hosono, et al.JACC. Cardiooncology|February 3, 2025
Concomitant Administration of Dantrolene is Sufficient to Protect Against Doxorubicin-Induced CardiomyopathyYoshihide Nakamura, Takeshi Yamamoto, Shigeki Kobayashi, et al.Pageof 8